- Home
- DRIO vs ENLV Comparison
DRIO vs ENLV Comparison
Compare DRIO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- ENLV
- Stock Information
- Founded
- DRIO 2011
- ENLV 2005
- Country
- DRIO United States
- ENLV Israel
- Employees
- DRIO N/A
- ENLV N/A
- Industry
- DRIO Medical/Dental Instruments
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- ENLV Health Care
- Exchange
- DRIO Nasdaq
- ENLV Nasdaq
- Market Cap
- DRIO 28.3M
- ENLV 23.7M
- IPO Year
- DRIO N/A
- ENLV 1995
- Fundamental
- Price
- DRIO $0.70
- ENLV $0.97
- Analyst Decision
- DRIO Strong Buy
- ENLV Strong Buy
- Analyst Count
- DRIO 2
- ENLV 2
- Target Price
- DRIO $2.50
- ENLV $10.00
- AVG Volume (30 Days)
- DRIO 138.4K
- ENLV 46.3K
- Earning Date
- DRIO 05-14-2025
- ENLV 05-30-2025
- Dividend Yield
- DRIO N/A
- ENLV N/A
- EPS Growth
- DRIO N/A
- ENLV N/A
- EPS
- DRIO N/A
- ENLV N/A
- Revenue
- DRIO $28,034,000.00
- ENLV N/A
- Revenue This Year
- DRIO $16.54
- ENLV N/A
- Revenue Next Year
- DRIO $21.93
- ENLV N/A
- P/E Ratio
- DRIO N/A
- ENLV N/A
- Revenue Growth
- DRIO 47.20
- ENLV N/A
- 52 Week Low
- DRIO $0.50
- ENLV $0.81
- 52 Week High
- DRIO $1.55
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- DRIO 50.29
- ENLV 49.07
- Support Level
- DRIO $0.63
- ENLV $0.93
- Resistance Level
- DRIO $0.72
- ENLV $0.98
- Average True Range (ATR)
- DRIO 0.04
- ENLV 0.05
- MACD
- DRIO -0.00
- ENLV -0.00
- Stochastic Oscillator
- DRIO 65.14
- ENLV 43.09
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.